 |
|
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi
Clin Mol Hepatol. 2023;29(2):242-251. Published online 2023 Mar 20 DOI: https://doi.org/10.3350/cmh.2023.0102
|
|
Citations to this article as recorded by
 Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma
Hiroyuki Suzuki, Hideki Iwamoto, Toshimitsu Tanaka, Takahiko Sakaue, Yasuko Imamura, Atsutaka Masuda, Toru Nakamura, Hironori Koga, Yujin Hoshida, Takumi Kawaguchi
Hepatology International.2024; 18(2): 610. CrossRef Case Reports of Pituitary Adrenocortical Insufficiency Following Atezolizumab+Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma
Etsuko Moriyama, Hideki Iwamoto, Takashi Niizeki, Ayako Nagayama, Tomotake Shirono, Shigeo Shimose, Masahito Nakano, Yu Noda, Hiroyuki Suzuki, Miwa Sakai, Ryoko Kuromatu, Hironori Koga, Masatoshi Nomura, Takumi Kawaguchi
Kanzo.2024; 65(1): 37. CrossRef Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
Tianying Ren, Xu Hou, Xin Zhang, Dongliang Chen, Juan Li, Yingnan Zhu, Zhiheng Liu, Dawei Yang
Heliyon.2023; 9(11): e21906. CrossRef Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort Study
Jonathan Abdelmalak, Simone I. Strasser, Natalie Ngu, Claude Dennis, Marie Sinclair, Avik Majumdar, Kate Collins, Katherine Bateman, Anouk Dev, Joshua H. Abasszade, Zina Valaydon, Daniel Saitta, Kathryn Gazelakis, Susan Byers, Jacinta Holmes, Alexander J.
Cancers.2023; 15(24): 5741. CrossRef
|